Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Drug Delivery|November 25, 2005
Complement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteinsJanos Szebeni
Current Allergy and Asthma Reports|December 19, 2003
Hypersensitivity reactions to radiocontrast media: the role of complement activationJanos Szebeni
Toxicology|September 6, 2005
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicityJanos Szebeni
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|April 1, 2011
[Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry]Janos Szebeni
Molecular Immunology|August 16, 2014
Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicalsJanos Szebeni
Pharmaceutics|July 30, 2025
Correction: Szebeni, J. Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent Challenges. Pharmaceutics 2025, 17, 450Janos Szebeni
Methods in Molecular Biology (Clifton, N.J.)|March 20, 2024
Evaluation of the Acute Anaphylactoid Reactogenicity of Nanoparticle-Containing Medicines and Vaccines Using the Porcine CARPA ModelJanos Szebeni
Pharmaceutics|April 26, 2025
Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease, and Platform-Inherent ChallengesJanos Szebeni
ACS Nano|July 10, 2020
Complement Activation: A Potential Threat on the Safety of Poly(ethylene glycol)-Coated NanomedicinesAlberto Gabizon, Janos Szebeni
Biochemical and Biophysical Research Communications|July 18, 2015
Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugsJanos Szebeni, Gert Storm
Pageof 5